Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €17.92 EUR
Change Today -1.05 / -5.54%
Volume 255.8K
ALM On Other Exchanges
Symbol
Exchange
Frankfurt
OTC US
Continuous
As of 8:28 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bertil Lindmark

Chief Scientific Officer, Member of Management Board, Executive Director for R&D and Member of Compliance Committee, Almirall, S.A.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Mr. Bertil Lindmark has been Chief Scientific Officer and Member of Management Board at Almirall, S.A. since January 2011 and serves as its Executive Director for R&D. Mr. Lindmark served as Executive Member of Board of Directors at Almirall, S.A.

Corporate Headquarters*

General Mitre, 151
Barcelona, Catalonia 08022

Spain

Phone: 34 93 291 30 00
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALM:SM €17.92 EUR -1.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$557.2K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$860.0K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Kåre Schultz Chief Executive Officer and President
H. Lundbeck A/S
--
Richard Martin Steeves Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
874.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALMIRALL SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.